Clinical Study
Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
Table 1
Comparison of baseline data between intravitreal aflibercept and bevacizumab for macular edema secondary to branch retinal occlusion.
| | | Aflibercept () | Bevacizumab () | value |
| | Age (years) | 63.3 ± 6.9 | 62.7 ± 5.5 | 0.34 | | Gender (male : female) | 13 : 12 | 12 : 15 | 0.12 | | Lens status (phakic : pseudophakic) | 22 : 3 | 20 : 7 | 0.09 | | Diabetic patients | 10 | 16 | 0.19 | | Duration of symptoms (days) | | | 0.23 | | Central foveal thickness (m) | | | 0.15 | | Best-corrected visual acuity (logMAR) | | | 0.17 |
|
|
